secwatch.observer — SEC 8-K summary
======================================

Issuer:     enVVeno Medical Corp (NVNO)
CIK:        0001661053
Form:       8-K
Filed at:   2026-01-20T23:59:59+00:00
Accession:  0001493152-26-002860
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enVVeno Medical effects 1:35 reverse stock split, shares outstanding drop to ~655,606
--------------------------------------------------------------------------------

- Reverse split ratio 1:35 effective Jan 20, 2026; no fractional shares issued, rounded up.
- Outstanding shares reduced from 22,946,223 to 655,606; authorized shares unchanged at 250M.
- Proportional adjustments made to stock options and warrants (e.g., exercise price increased 35x).
- Common stock began trading on split-adjusted basis Jan 20, 2026; transfer agent Equiniti managing exchange.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661053/000149315226002860/0001493152-26-002860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661053/000149315226002860/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer